G1 Therapeutics and Genor Biopharma sign agreement for Lerociclib EP News Bureau Jun 23, 2020 As per the exclusive license agreement, Genor to lead clinical development, regulatory submissions and commercialisation of…
CSIR’s anti-cancer drug IIIM-290 goes into clinical trial Press Information Bureau Jun 9, 2020 The clinical trial aims to assess safety, tolerability and exposure of the compound in humans along with the early efficacy…
Drug developers take fresh aim at ‘guided-missile’ cancer drugs Reuters Jan 7, 2020 These antibody-drug conjugates, or ADCs, from companies including AztraZeneca and GlaxoSmithKline, are described by researchers as…
